{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:59:31Z","timestamp":1790643571214,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100004896","name":"Eisai Incorporated","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004896","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"DOI":"10.1007\/s40120-026-01036-5","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T12:01:08Z","timestamp":1790596868000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From Biomarker Anchors to Disease-State Transitions: A Biologically Anchored Probabilistic Principal Component Analysis Framework for Alzheimer\u2019s Disease Progression Modeling"],"prefix":"10.1007","author":[{"given":"Babak","family":"Haji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4003-3192","authenticated-orcid":false,"given":"Amir Abbas","family":"Tahami Monfared","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"issue":"4","key":"1036_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239\u201359.","journal-title":"Acta Neuropathol"},{"issue":"12","key":"1036_CR2","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, Rub U, Orantes M, Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology. 2002;58(12):1791\u2013800.","journal-title":"Neurology"},{"issue":"2","key":"1036_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack Jr.","year":"2013","unstructured":"Jack CR Jr., Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, et al. Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12(2):207\u201316.","journal-title":"Lancet Neurol"},{"issue":"1","key":"1036_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","volume":"9","author":"CR Jack Jr.","year":"2010","unstructured":"Jack CR Jr., Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, et al. Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade. Lancet Neurol. 2010;9(1):119\u201328.","journal-title":"Lancet Neurol"},{"issue":"4","key":"1036_CR5","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362.","journal-title":"Alzheimers Dement"},{"issue":"5","key":"1036_CR6","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","volume":"87","author":"CR Jack Jr.","year":"2016","unstructured":"Jack CR Jr., Bennett DA, Blennow K, Carrillo MC, Feldman HH, Frisoni GB, et al. A\/T\/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology. 2016;87(5):539\u201347.","journal-title":"Neurology"},{"issue":"8","key":"1036_CR7","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr","year":"2024","unstructured":"Jack CR Jr, Andrews JS, Beach TG, Buracchio T, Dunn B, Graf A, et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement. 2024;20(8):5143\u201369.","journal-title":"Alzheimers Dement"},{"key":"1036_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cimb47080580","author":"L Agnello","year":"2025","unstructured":"Agnello L, Gambino CM, Ciaccio AM, Cacciabaudo F, Massa D, Masucci A, et al. From amyloid to synaptic dysfunction: biomarker-driven insights into Alzheimer\u2019s disease. Curr Issues Mol Biol. 2025. https:\/\/doi.org\/10.3390\/cimb47080580.","journal-title":"Curr Issues Mol Biol"},{"issue":"4","key":"1036_CR9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10072-026-08931-7","volume":"47","author":"L Gaetani","year":"2026","unstructured":"Gaetani L, Agnello L, Pilotto A, Benussi A, Cagnin A, Parnetti L, et al. Blood-based biomarkers for Alzheimer\u2019s disease diagnosis: a joint position paper from the Italian Societies of Neurology (SIN) and of Clinical Biochemistry and Clinical Molecular Biology \u2013 Laboratory Medicine (SIBioC) and from the Autonomous Association affiliated with SIN for dementia (SINdem). Neurol Sci. 2026;47(4):355. https:\/\/doi.org\/10.1007\/s10072-026-08931-7.","journal-title":"Neurol Sci."},{"issue":"3","key":"1036_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","volume":"74","author":"RC Petersen","year":"2010","unstructured":"Petersen RC, Aisen PS, Beckett LA, Donohue MC, Gamst AC, Harvey DJ, et al. Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology. 2010;74(3):201\u20139.","journal-title":"Neurology"},{"issue":"4","key":"1036_CR11","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ana.21610","volume":"65","author":"LM Shaw","year":"2009","unstructured":"Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, et al. Cerebrospinal fluid biomarker signature in Alzheimer\u2019s disease neuroimaging initiative subjects. Ann Neurol. 2009;65(4):403\u201313.","journal-title":"Ann Neurol"},{"issue":"3","key":"1036_CR12","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/1467-9868.00196","volume":"61","author":"MEBCM Tipping","year":"1999","unstructured":"Tipping MEBCM. Probabilistic principal component analysis. J R Stat Soc Ser B Stat Methodol. 1999;61(3):611\u201322.","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"1036_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2023.120279","volume":"278","author":"M Saint-Jalmes","year":"2023","unstructured":"Saint-Jalmes M, Fedyashov V, Beck D, Baldwin T, Faux NG, Bourgeat P, et al. Disease progression modelling of Alzheimer\u2019s disease using probabilistic principal components analysis. Neuroimage. 2023;278:120279.","journal-title":"Neuroimage"},{"key":"1036_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-026-00940-0","author":"B Haji","year":"2026","unstructured":"Haji B, Tahami Monfared AA, Alzheimer\u2019s Disease Neuroimaging I. A multimodal latent severity axis for Alzheimer\u2019s disease: probabilistic PCA, Bayesian trajectories, and stage-aware timing effects. Neurol Ther. 2026. https:\/\/doi.org\/10.1007\/s40120-026-00940-0.","journal-title":"Neurol Ther"},{"issue":"7","key":"1036_CR15","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s40273-016-0392-1","volume":"34","author":"L Hernandez","year":"2016","unstructured":"Hernandez L, Ozen A, DosSantos R, Getsios D. Systematic review of model-based economic evaluations of treatments for Alzheimer\u2019s disease. Pharmacoeconomics. 2016;34(7):681\u2013707.","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"1036_CR16","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1007\/s40120-023-00498-1","volume":"12","author":"AA Tahami Monfared","year":"2023","unstructured":"Tahami Monfared AA, Fu S, Hummel N, Qi L, Chandak A, Zhang R, et al. Estimating transition probabilities across the Alzheimer\u2019s disease continuum using a nationally representative real-world database in the United States. Neurol Ther. 2023;12(4):1235\u201355.","journal-title":"Neurol Ther"},{"issue":"5","key":"1036_CR17","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1002\/alz.12811","volume":"19","author":"RLH Handels","year":"2023","unstructured":"Handels RLH, Green C, Gustavsson A, Herring WL, Winblad B, Wimo A, et al. Cost-effectiveness models for Alzheimer\u2019s disease and related dementias: IPECAD modeling workshop cross-comparison challenge. Alzheimers Dement. 2023;19(5):1800\u201320.","journal-title":"Alzheimers Dement"},{"issue":"10","key":"1036_CR18","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1080\/02664763.2010.547567","volume":"38","author":"RA Hubbard","year":"2011","unstructured":"Hubbard RA, Zhou XH. A comparison of non-homogeneous Markov regression models with application to Alzheimer\u2019s disease progression. J Appl Stat. 2011;38(10):2313\u201326.","journal-title":"J Appl Stat"},{"issue":"1","key":"1036_CR19","doi-asserted-by":"publisher","first-page":"10.4172\/2155-61","DOI":"10.4172\/2155-6180.1000e122","volume":"4","author":"RJ Kryscio","year":"2013","unstructured":"Kryscio RJ, Abner EL. Are Markov and semi-Markov models flexible enough for cognitive panel data? J Biom Biostat. 2013;4(1):10.4172\/2155-6180.1000e122. https:\/\/doi.org\/10.4172\/2155-6180.1000e122.","journal-title":"J Biom Biostat."},{"key":"1036_CR20","doi-asserted-by":"publisher","first-page":"c3666","DOI":"10.1136\/bmj.c3666","volume":"341","author":"S Debette","year":"2010","unstructured":"Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2010;341:c3666.","journal-title":"BMJ"},{"issue":"5","key":"1036_CR21","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","volume":"74","author":"N Mattsson","year":"2017","unstructured":"Mattsson N, Andreasson U, Zetterberg H, Blennow K, Alzheimer\u2019s Disease Neuroimaging I. Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease. JAMA Neurol. 2017;74(5):557\u201366.","journal-title":"JAMA Neurol"},{"issue":"4","key":"1036_CR22","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.neuroimage.2010.06.025","volume":"53","author":"J Barnes","year":"2010","unstructured":"Barnes J, Ridgway GR, Bartlett J, Henley SM, Lehmann M, Hobbs N, et al. Head size, age and gender adjustment in MRI studies: a necessary nuisance? Neuroimage. 2010;53(4):1244\u201355.","journal-title":"Neuroimage"},{"key":"1036_CR23","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3389\/fnagi.2014.00264","volume":"6","author":"O Voevodskaya","year":"2014","unstructured":"Voevodskaya O, Simmons A, Nordenskjold R, Kullberg J, Ahlstrom H, Lind L, et al. The effects of intracranial volume adjustment approaches on multiple regional MRI volumes in healthy aging and Alzheimer\u2019s disease. Front Aging Neurosci. 2014;6:264.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"1036_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.2517-6161.1977.tb01600.x","volume":"39","author":"AP Dempster","year":"1977","unstructured":"Dempster AP, Laird NM, Rubin DB. Maximum likelihood from incomplete data via the EM algorithm. J R Stat Soc Ser B Stat Methodol. 1977;39(1):1\u201322.","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"1036_CR25","first-page":"57","volume":"2","author":"U Lorenzo-Seva","year":"2006","unstructured":"Lorenzo-Seva U, Berge JMF. Tucker\u2019s congruence coefficient as a meaningful index of factor similarity. Methodol Eur J Res Methods Behav Soc Sci. 2006;2:57\u201364.","journal-title":"Methodol Eur J Res Methods Behav Soc Sci"},{"issue":"8","key":"1036_CR26","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/S0895-4356(01)00341-9","volume":"54","author":"EW Steyerberg","year":"2001","unstructured":"Steyerberg EW, Harrell FE Jr, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol. 2001;54(8):774\u201381.","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"1036_CR27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR. Regression models and life-tables. J R Stat Soc Ser B Stat Methodol. 1972;34(2):187\u2013202.","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"issue":"18","key":"1036_CR28","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1001\/jama.1982.03320430047030","volume":"247","author":"FE Harrell Jr","year":"1982","unstructured":"Harrell FE Jr, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA. 1982;247(18):2543\u20136.","journal-title":"JAMA"},{"issue":"6","key":"1036_CR29","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.jalz.2011.01.005","volume":"7","author":"N Coley","year":"2011","unstructured":"Coley N, Andrieu S, Jaros M, Weiner M, Cedarbaum J, Vellas B. Suitability of the clinical dementia rating-sum of boxes as a single primary endpoint for Alzheimer\u2019s disease trials. Alzheimers Dement. 2011;7(6):602-10 e2.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"1036_CR30","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","volume":"25","author":"O Preische","year":"2019","unstructured":"Preische O, Schultz SA, Apel A, Kuhle J, Kaeser SA, Barro C, et al. Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer\u2019s disease. Nat Med. 2019;25(2):277\u201383.","journal-title":"Nat Med"},{"key":"1036_CR31","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.neuroimage.2018.11.024","volume":"186","author":"V Venkatraghavan","year":"2019","unstructured":"Venkatraghavan V, Bron EE, Niessen WJ, Klein S, Alzheimer\u2019s Disease Neuroimaging I. Disease progression timeline estimation for Alzheimer\u2019s disease using discriminative event based modeling. Neuroimage. 2019;186:518\u201332.","journal-title":"Neuroimage"},{"issue":"3","key":"1036_CR32","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1016\/j.neuroimage.2012.01.062","volume":"60","author":"HM Fonteijn","year":"2012","unstructured":"Fonteijn HM, Modat M, Clarkson MJ, Barnes J, Lehmann M, Hobbs NZ, et al. An event-based model for disease progression and its application in familial Alzheimer\u2019s disease and Huntington\u2019s disease. Neuroimage. 2012;60(3):1880\u20139.","journal-title":"Neuroimage"},{"issue":"Pt 9","key":"1036_CR33","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1093\/brain\/awu176","volume":"137","author":"AL Young","year":"2014","unstructured":"Young AL, Oxtoby NP, Daga P, Cash DM, Fox NC, Ourselin S, et al. A data-driven model of biomarker changes in sporadic Alzheimer\u2019s disease. Brain. 2014;137(Pt 9):2564\u201377.","journal-title":"Brain"},{"issue":"5 Suppl","key":"1036_CR34","first-page":"S400","volume":"10","author":"MC Donohue","year":"2014","unstructured":"Donohue MC, Jacqmin-Gadda H, Le Goff M, Thomas RG, Raman R, Gamst AC, et al. Estimating long-term multivariate progression from short-term data. Alzheimers Dement. 2014;10(5 Suppl):S400\u201310.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1036_CR35","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1038\/s41467-018-05892-0","volume":"9","author":"AL Young","year":"2018","unstructured":"Young AL, Marinescu RV, Oxtoby NP, Bocchetta M, Yong K, Firth NC, et al. Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference. Nat Commun. 2018;9(1):4273.","journal-title":"Nat Commun"},{"issue":"8","key":"1036_CR36","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1002\/alz.12293","volume":"17","author":"KZ Gianattasio","year":"2021","unstructured":"Gianattasio KZ, Bennett EE, Wei J, Mehrotra ML, Mosley T, Gottesman RF, et al. Generalizability of findings from a clinical sample to a community-based sample: a comparison of ADNI and ARIC. Alzheimers Dement. 2021;17(8):1265\u201376.","journal-title":"Alzheimers Dement"},{"issue":"11","key":"1036_CR37","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.jalz.2018.01.010","volume":"14","author":"O Hansson","year":"2018","unstructured":"Hansson O, Seibyl J, Stomrud E, Zetterberg H, Trojanowski JQ, Bittner T, et al. CSF biomarkers of Alzheimer\u2019s disease concord with amyloid-beta PET and predict clinical progression: a study of fully automated immunoassays in BioFINDER and ADNI cohorts. Alzheimers Dement. 2018;14(11):1470\u201381.","journal-title":"Alzheimers Dement"},{"issue":"18","key":"1036_CR38","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1212\/WNL.0b013e318253d5b3","volume":"78","author":"RY Lo","year":"2012","unstructured":"Lo RY, Jagust WJ, Alzheimer\u2019s Disease Neuroimaging I. Predicting missing biomarker data in a longitudinal study of Alzheimer disease. Neurology. 2012;78(18):1376\u201382.","journal-title":"Neurology"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-026-01036-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-026-01036-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-026-01036-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:02:56Z","timestamp":1790640176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-026-01036-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":38,"alternative-id":["1036"],"URL":"https:\/\/doi.org\/10.1007\/s40120-026-01036-5","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"3 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Babak Haji is an employee of Eisai Inc. Amir Abbas Tahami Monfared is also an employee of Eisai Inc. and holds the position of Adjunct Professor in the Department of Epidemiology, Biostatistics, and Occupational Health at McGill University. Additionally, he serves as an Associate Editor for the\n                      Journal of Alzheimer's Disease\n                      , a voluntary position for which he receives no honoraria. In this role, he was not involved in the peer-review or editorial decision-making for this manuscript and had no access to any related peer-review information.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Data used in this study were obtained from the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) database through the ADNI data-sharing mechanism. Informed consent was obtained from all participants enrolled in ADNI in accordance with its study protocols. The present study involved secondary analysis of de-identified data and did not include any new research conducted by the authors involving human participants or animals. The study was conducted in accordance with the ethical principles of the 1964 Declaration of Helsinki and its later amendments, or comparable ethical standards.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}